Concepedia

Author

Heather L. Jackson

GlaxoSmithKline (United States)

Also Known As

H. Jackson, Heather Jackson, Heather L. Jackson

28

Publications

246

Citations

5

H-Index

0

Concepts

All Affiliations

GlaxoSmithKline (United States)GlaxoSmithKline (United Kingdom)The University of Texas MD Anderson Cancer Center
HL

About

Heather L. Jackson is an author at GlaxoSmithKline (United States).

Heather L. Jackson

×

4

Publications

228

Citations

4

H-Index

YearCitations

Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses<i>In Vivo</i>

Rocío Montes de, Alireza Alavi, Nick Vitali,

Molecular Cancer Therapeutics

2021

99

Radiation Followed by OX40 Stimulation Drives Local and Abscopal Antitumor Effects in an Anti–PD1-Resistant Lung Tumor Model

Sharareh Niknam, Hampartsoum B. Barsoumian, Jonathan E. Schoenhals,

Clinical Cancer Research

2018

58

Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss Melanoma

Weiyi Peng, Leila J. Williams, Chunyu Xu,

Clinical Cancer Research

2019

43

Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth

Heather L. Jackson, David Granger, Gavin C. Jones,

Molecular Cancer Research

2016

28

Page 1